SWS Hemodialysis Care Co (SHSE:688410) DeferredTaxAndRevenue: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688410 SWS Hemodialysis Care Co Ltd SHSE:688410
88 GF Score
Price ¥11.11
GF Value ¥14.86
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is SWS Hemodialysis Care Co DeferredTaxAndRevenue?

SWS Hemodialysis Care Co SHSE:688410 -0.45% 88 DeferredTaxAndRevenue is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688410 with a GF Score™ of 88/100 and a GF Value™ of ¥14.86 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

SWS Hemodialysis Care Co's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

SWS Hemodialysis Care Co DeferredTaxAndRevenue Related Terms


SWS Hemodialysis Care Co DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for SWS Hemodialysis Care Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SWS Hemodialysis Care Co DeferredTaxAndRevenue Chart

SWS Hemodialysis Care Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SWS Hemodialysis Care Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:688410
88GF Score
SWS Hemodialysis Care Co Ltd SHSE:688410
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ¥0.0 Mil mean?
SWS Hemodialysis Care Co (SHSE:688410) has a DeferredTaxAndRevenue of ¥0.0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on SWS Hemodialysis Care Co.
Is SWS Hemodialysis Care Co's DeferredTaxAndRevenue too high?
SWS Hemodialysis Care Co's current DeferredTaxAndRevenue is ¥0.0 Mil. Overall, SWS Hemodialysis Care Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's DeferredTaxAndRevenue compare to ISRG and BDX?
SWS Hemodialysis Care Co's DeferredTaxAndRevenue of ¥0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on SWS Hemodialysis Care Co. SWS Hemodialysis Care Co's current DeferredTaxAndRevenue is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.86, compared to a current price of ¥11.11 — trading 25.2% below its estimated fair value. The current DeferredTaxAndRevenue is ¥0.0 Mil. SWS Hemodialysis Care Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current DeferredTaxAndRevenue is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?

Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued. The current stock price of ¥11.11 is trading 25.2% below its estimated GF Value™ of ¥14.86. GuruFocus considers SWS Hemodialysis Care Co to be Modestly Undervalued.

Key valuation signals for SHSE:688410:

  • DeferredTaxAndRevenue: ¥0.0 Mil
  • GF Value™: ¥14.86 vs. price of ¥11.11 (25.2% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SWS Hemodialysis Care Co Business Description

Address No. 1, Ciji Road, Liangjiang New District, Chongqing, CHN, 401123
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
88GF Score

Get the complete analysis for SHSE:688410

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.11
Price
¥14.86
GF Value